Quality of life against seasonal vs perennial allergens: ESPRINT-15 modified in the pediatric population
Main Article Content
Keywords
ESPRINT-15, rhinitis, quality of life, childhood allergy, HRQoL, SarsCov-2, prevention
Abstract
Introduction: Allergic rhinitis (AR) is a clinical syndrome characterized by IgE-mediated inflammation of the nasal mucosa. The present study investigates the quality of life (QoL) with AR among adults, using widely validated questionnaires, unlike in pediatric patients.
Materials and methods: A cross-sectional descriptive observational study was conducted, analyzing the QoL of 102 children with AR aged between 10-15 years, belonging to two health centers (HC) in Zaragoza and two HC in Coruña. The comparison of means between the two groups is carried out using the Student's test or the Mann-Whitney test, considering a value of p˂0.05 to be significant.
Results: Around 102 children were studied, with a majority (59.8%) being male and a mean age of 12 years. Around 76.5% have a family history of atopy. It was found that AR is more prevalent in Zaragoza (p ˂0.005), and asthmais highly prevalent in Coruña (p ˂0.001). The most important sensitizations are pollen in Zaragoza (p ˂0.05) and dust mites in A Coruña (p ˂0.001). More treatment needs and associated comorbidities (p˂0.05) were observed in A Coruña. The results of the ESPRINT-15 show that 63% of the patients have a good QoL, 27% fair, and 8.8%, poor. Those sensitized to mites have a worse score (p = 0.02). It was found that 52% of children experienced improvement during home confinement, with no notable differences between the two populations. The use of the mask favored QoL in patients from Zaragoza (p ˂0.001).
Conclusion: It was concluded that AR influences the QoL in pediatric patients. Greater QoL involvement, need for treatment, and comorbidities are observed in patients sensitized to dust mites compared to those sensitized to pollens. It was also observed that masks improved the symptoms, stopping patients being sensitized to pollens.
References
2. Spanish GI. Prevalence of symptoms suggestive of allergic rhinitis and atopic dermatitis in adolescents (ISAAC Spain Study). An Esp Pediatr. 1999;51(4):369–76.
3. Arnedo-Pena A, García-Marcos L, García Hernández G, Aguinagua Ontoso I, González Díaz C, Morales Suárez-Varela M, et al. Temporal trend and geographical variations of the prevalence of allergic rhinitis symptoms in schoolchildren aged 6-7 years from eight Spanish areas, according to the ISAAC. An Pediatr. 2005;62(3):229–36. 10.1157/13071837
4. Judges CR. Animals and others. Avoidance measures. 2019;(1): 65–85.
5. Aerobiology Committee. [Internet]. SEAIC. 2021. Available from: https://www.polenes.com/en/home
6. Rossen RD, Birdsall HH. Allergy and immunology. Internal Med Secrets. 2006;6(1):451–10. 10.1016/B978-84-8174-886-4.50012-X
7. Lucas Moreno JM, Moreno Salvador AO, Ortega Bernal MG Allergic pathology of the upper respiratory tract. Protoc diagn ter pediatr. 2019;2:133-48.
8. Colomer MC. Allergic rhinitis. Offarm. 2004;23:146–7.
9. Service E, Immunology D, Pediatric A, Integrated U. Allergic rhinoconjunctivitis. 2013;(8):564–73. 32
10. Montoro J, Del Cuvillo A, Mullol J, Molina X, Bartra J, Dávila I, et al. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: The PEDRIAL study. Allergy Eur J Allergy Clin Immunol. 2012;67(11):1437–42. 10.1111/all.12011
11. Schuler IV CF, Montejo JM. Allergic Rhinitis in Children and Adolescents. Pediatr Clin North Am [Internet]. 2019;66(5):981–93. 10.1016/j.pcl.2019.06.004
12. GEMA 5.0. Guía española para el manejo del asma. Spanish Society of Pulmonology and Thoracic Surgery. 5th. ed. Maidenhead: Luzán 5 Health Consulting, S.A. 2021
13. Valls-Mateus M, Marino-Sanchez F, Ruiz-Echevarría K, Cardenas-Escalante P, Jiménez-Feijoo R, Blasco-Lozano J, et al. Nasal obstructive disorders impair health-related quality of life in adolescents with persistent allergic rhinitis: A real-life study. Pediatr Allergy Immunol. 2017;28(5):438–45. 10.1111/pai.12724
14. Sobrevia Elfau MT, Ferrer Clavería L, Rojas Hijazo B, Colás Sanz C. Quality of life in allergic rhinitis. ENT Aragon. 2009;12(1):9–14.
15. Ivette M, Hernández M, Reyes HM, Margarita A, Rodríguez C, Reyes CM, et al. Original article Evaluation of the quality of life in patients with allergic rhinitis. Quality. 2009;54:102–8.
16. Valero A, Baró E, Sastre J, Navarro-Pulido AM, Izquierdo I, Martí-Guadaño E, et al. Reference values for facilitating the interpretation of the ESPRINT-15 Questionnaire (Spanish Version). J Investig Allergol Clin Immunol. 2009;19(5):396–3.
17. Cedeño-Zavalu VM, Alonso-Muñiz GR, Quijije-Segovia SK, Sornoza-Pin AA, Cepeda-García LP, Castillo-Chávez KD. Estrategias para una calidad de vida en pacientes con rinitis alérgicas. Dom Cien. 2018;4:255–269. 10.23857/dc.v4i4.839
18. Izquierdo-Domínguez A, Valero AL, Mullol J. Comparative analysis of allergic rhinitis in children and adults. Curr Allergy Asthma Rep. 2013;13(2):142–51. 10.1007/s11882-012-0331-y
19. Blaiss MS, Hammerby E, Robinson S, Kennedy-Martin T, Buchs S. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: A literature review. Ann Allergy, Asthma Immunol. 2018;121(1):43–52. 10.1016/j.anai.2018.03.028
20. Devillier P, Bousquet PJ, Grassin-Delyle S, Salvator H, Demoly P, Bousquet J, et al. Comparison of outcome measures in allergic rhinitis in children, adolescents and adults. Pediatr Allergy Immunol. 2016;27(4):375–81. 10.1111/pai.12561
21. Silva MGN, Naspitz CK, Solé D. Evaluation of quality of life in children and adolescents with allergic rhinitis: Adaptation and validation of the rhinoconjunctivitis quality of life questionnaire (RQLQ). Allergol Immunopathol. 2001;29(4):111–8. 10.1016/S0301-0546(01)79042-8
22. Begin P, Nadeau KC. Epigenetic regulation of asthma and allergic disease. Allergy, Asthma Clin Immunol. 2014;10(1):1–12. 10.1186/1710-1492-10-27
23. Meltzer EO. allergic rhinitis. Burden of Illness, Quality of Life, Comorbidities, and Control. Immunol Allergy Clin North Am. 2016;36(2):235–48. 10.1016/j.iac.2015.12.0
24. Mastrorilli C, Posa D, Cipriani F, Caffarelli C. Asthma and allergic rhinitis in childhood: what's new. Pediatr Allergy Immunol. 2016;27(8):795–803. 10.1111/pai.12681
25. Dykewicz MS, Wallace D V, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol. 2020;146(4):721–67. 10.1016/j.jaci.2020.07.007
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.